Cohort information
Min | Max | Median | |||
Age at diagnosis (years) | 38 | 89 | 64 | ||
Time to relapse (years) | 0.5 | 13.9 | 1.7 | ||
Sex | |||||
Male | Female | ||||
17 | 21 | ||||
Cell of Origin | |||||
(Avaliable for 35 cases) | Relapse | ||||
ABC | GCB | UNC | |||
Diagnosis | ABC | 17 | 1 | 2 | |
GCB | 0 | 11 | 1 | ||
UNC | 1 | 0 | 2 | ||
Site of Biopsy | |||||
Relapse | |||||
Nodal | Extranodal | ||||
Diagnosis | Nodal | 8 | 7 | ||
Extranodal | 11 | 12 | |||
Treatment | |||||
Treatment | Frequency | ||||
R-CHOP | 30 | ||||
R-CHOP + IT MTX | 3 | ||||
R-CHOP + LOCALISED RT | 1 | ||||
R-CHOP X3 + IT MTX AND IFRT | 1 | ||||
R-CHOP X3 + RADIOTHERAPY | 1 | ||||
R-CEOP | 1 | ||||
R-CEOP + RADIOTHERAPY | 1 |
Min | Max | Median | |||
Age at diagnosis (years) | 38 | 89 | 64 | ||
Time to relapse (years) | 0.5 | 13.9 | 1.7 | ||
Sex | |||||
Male | Female | ||||
17 | 21 | ||||
Cell of Origin | |||||
(Avaliable for 35 cases) | Relapse | ||||
ABC | GCB | UNC | |||
Diagnosis | ABC | 17 | 1 | 2 | |
GCB | 0 | 11 | 1 | ||
UNC | 1 | 0 | 2 | ||
Site of Biopsy | |||||
Relapse | |||||
Nodal | Extranodal | ||||
Diagnosis | Nodal | 8 | 7 | ||
Extranodal | 11 | 12 | |||
Treatment | |||||
Treatment | Frequency | ||||
R-CHOP | 30 | ||||
R-CHOP + IT MTX | 3 | ||||
R-CHOP + LOCALISED RT | 1 | ||||
R-CHOP X3 + IT MTX AND IFRT | 1 | ||||
R-CHOP X3 + RADIOTHERAPY | 1 | ||||
R-CEOP | 1 | ||||
R-CEOP + RADIOTHERAPY | 1 |